Dostarlimab shows dose-dependent immune activation of the tumor microenvironment in a patient-derived NSCLC explant model similar to pembrolizumab

被引：0
|
作者：
Perrin, Jessica
Wippich, Frank
Sherina, Valeriia
Dvornikov, Dmytro
Lupar, Katharina
Melhem, Murad M.
Hanafin, Patrick
Waight, Jeremy
Yu, Jong
Yadavilli, Sapna
Poeckel, Daniel
Bergamini, Giovanna
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-6647
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6647
引用
收藏
页数：2
相关论文
共 38 条
  • [31] Quantitative examination of the inhibitory activation of molecular targeting agents in hepatocellular carcinoma patient-derived cell invasion via a novel in vivo tumor model
    Sun, Huiwei
    Feng, Fan
    Xie, Hui
    Li, Xiaojuan
    Jiang, Qiyu
    Chai, Yantao
    Wang, Zhijie
    Yang, Ruichuang
    Li, Ruisheng
    Hou, Jun
    ANIMAL MODELS AND EXPERIMENTAL MEDICINE, 2019, 2 (04) : 259 - 268
  • [32] Falcon-X 3D in vitro tumor model platform for screening patient-derived NSCLC, CRC, and RCC tumors with targeted therapy and immunotherapy.
    Xue, Bin
    Schueler, Julia
    Jensen, Timothy
    Hribar, Kolin C.
    CANCER RESEARCH, 2021, 81 (13)
  • [33] GM-CSF AND IL-3 EXPRESSION INCREASES IMMUNE ENGRAFTMENT AND TUMOR INFILTRATION IN A HUMANIZED PATIENT-DERIVED XENOGRAFT MODEL OF HEPATOCELLULAR CARCINOMA
    Weinfurtner, Kelley
    Crainic, Jennifer
    Li, Wuyan
    Ackerman, Daniel
    Hunt, Stephen J.
    Nadolski, Gregory J., II
    Kaplan, David E.
    Gade, Terence P. F.
    HEPATOLOGY, 2021, 74 : 692A - 692A
  • [34] Varlitinib demonstrates tumor regression and vessel normalization in ErbB-dependent and mutated beta-catenin hepatocellular carcinoma patient-derived xenograft model
    Shuen, Wai Ho
    Ong, Richard
    Yeo, Chloe
    Banu, Rebecca
    Koh, Lip Seng
    Chee, Chit Lai
    Seet, Qihui
    Ooi, Lisa
    McHale, Mark
    Lindmark, Bertil
    Toh, Han Chong
    Hung, Huynh
    CANCER RESEARCH, 2018, 78 (13)
  • [35] MONITORING THE IMPACT OF MDSC TARGETING DRUGS IN COMBINATION WITH NIVOLUMAB ON ACTIVATION AND PROLIFERATION OF TUMOR RESIDENT EFFECTOR IMMUNE CELLS IN PATIENT-DERIVED 3D-EXPLORE PLATFORM
    Ehrhart, Jared
    Bunch, Brittany
    Sussman, Kelly
    Guzman, Kelly
    Altiok, Soner
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A616 - A616
  • [36] Assessing the impact of cGAS-STING pathway activation on adoptive cell therapy using a patient-derived 3D ex vivo tumor organoid model
    Pabon, M.
    Pastoor, T.
    Ehrhart, J.
    Kreahling, J.
    Altiok, S.
    EUROPEAN JOURNAL OF CANCER, 2020, 138 : S59 - S59
  • [37] CXCR4 inhibition enhances anti-tumor immune response in an ex vivo autologous patient-derived organoids and PBMC model system of pancreatic ductal adenocarcinoma
    Pellicciotta, Ilenia
    CANCER RESEARCH, 2024, 84 (02)
  • [38] Merestinib (LY2801653), targeting several oncokinases including NTRK1/2/3, shows potent anti-tumor effect in colorectal cell line- and patient-derived xenograft (PDX) model bearing TPM3-NTRK1 fusion
    Konicek, Bruce W.
    Bray, Steve M.
    Capen, Andrew R.
    Calley, John N.
    Credille, Kelly M.
    Ebert, Philip J.
    Heady, Gary
    Patel, Bharvin K.
    Peek, Victoria L.
    Stephens, Jennifer R.
    Urn, Suzane L.
    Willard, Melinda D.
    Wulur, Isabella H.
    Zeng, Yi
    Walgren, Richard A.
    Yan, Sau-Chi Betty
    CANCER RESEARCH, 2016, 76
1234